Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 EUR | 0.00% |
|
-9.30% | -88.24% |
24/06 | Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from S&P Pharmaceuticals Select Industry Index | CI |
17/06 | Sector Update: Health Care Stocks Decline Premarket Monday | MT |
Sales 2024 * | 39.35M 36.81M 3.28B | Sales 2025 * | 58.17M 54.4M 4.85B | Capitalization | 67.57M 63.2M 5.64B |
---|---|---|---|---|---|
Net income 2024 * | -119M -111M -9.93B | Net income 2025 * | -78M -72.95M -6.51B | EV / Sales 2024 * | -1.52 x |
Net cash position 2024 * | 127M 119M 10.64B | Net cash position 2025 * | 54.53M 51M 4.55B | EV / Sales 2025 * | 0.22 x |
P/E ratio 2024 * |
-0.62
x | P/E ratio 2025 * |
-1.18
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.86% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | -9.30% | ||
Current month | -13.33% | ||
1 month | -7.87% | ||
3 months | -85.73% | ||
6 months | -88.24% | ||
Current year | -88.24% |
![Extreme 1.15](/images/extremecours_fleche.png)
![Extreme 1.15](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/21/12 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/19/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/08/01 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/19/12 |
Date | Price | Change |
---|---|---|
28/24/28 | 1.17 | 0.00% |
27/24/27 | 1.17 | -3.31% |
26/24/26 | 1.21 | -3.20% |
25/24/25 | 1.25 | -0.79% |
24/24/24 | 1.26 | -0.79% |
Real-time BOERSE MUENCHEN, June 28, 2024 at 11:30 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.95% | 819B | |
+43.62% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+16.30% | 242B | |
+2.41% | 225B | |
+12.47% | 217B | |
+8.91% | 168B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock